Degree | Type | Year | Semester |
---|---|---|---|
2500502 Microbiology | OB | 2 | 2 |
Is essential to have a good level of spoken and written English and a general background in Biochemistry, Molecular Biology, Cell Biology, Microbiology and Immunology.
*All teaching activities and assessments will be carried out in English in any context (face-to-face, semipresential or online).
The teaching objectives of the course are the acquisition by students of basic knowledge about the biology, structure, genetics and evolution of viruses within the framework of its pathogenesis and pharmacological possibilities and research opportunities virology can offer in those fields. It will be also focused on emerging applications of the viruses in biotechnology and nanotechnology, and the need for constant updating of information through bibliographic databases.
1. An introduction to viruses and Virology
The world of viruses. Strict parasitism, multiplication and transmission. The viral disease and the concept of "iceberg". Viral diversity. The viral particle: size, chemical composition, morphology and nomenclature. Functions of the capsid, stability and recognition. Chemical composition, structure and organization of the viral genome: structural and non-structural genes. The polarity of the nucleic acid. The viral cycle: extracellular and intracellular phases. Virus multiplication: productive and non-productive infection. Sequential expression of viral genes. Viruses, mobile genetic elements and living beings.
2. Historical overview of Virology
Hypotheses about the maintenance of life and spontaneous generation. The work of Pasteur. Microscopic infectious agents and Koch's postulates. The nineteenth century: the discovery of viruses. The tobacco mosaic virus: the concept of "filtrable infectious agent". Discovery of animal viruses. The twentieth century: characterization, chemical and genetic structure of viruses. Significant events in the history of virology. The eradication of smallpox and the risk of re-emergence. Clinical aspects of virology and biotechnology. Bioterrorism.
3. Viral multiplication
Cell recognition. Nature and function of receptors. Internalization. Uncoating. The cellular shutdown. Stimulation of cellular functions: papovavirus and adenovirus. Synthesis of RNA, DNA and viral proteins: temporal sequences. Cytopathic effects. Exit of viral particles with and without lysis. Apoptosis. Cellular transformationin RNA virus: cellular oncogenes,activation and transduction. Cellular transformation in DNA virus: viral oncogenes and oncoproteins. Processing of viral proteins. Targets for antiviral drugs. RNA interference.
4. Viral structure
Morphology of viral particles. Architectonic study of viral particles: electron microscopy and three-dimensional reconstructions. The X-ray diffraction: requirements and level of crystallographic resolution. Molecular architecture of helical and icosaedrical symmetry. Trans-membrane proteins in viral envelopes. Receptor binding sites. The viral antigens and epitopes B and T. The neutralization and evasion of antibody neutralization. Genetic and epitopic variability.
5. Viral genomes and genetics
Principles of economy and complexity of the viral genome, overlapping genes. Segmented and multipartite genomes. Sequencing of viral genomes and function prediction. Recombination, rearrangement and phenotypic mixing. Types of viral mutants. Defective viruses: integrated rearrangement and phenotypic mixing. Types of viral mutants. Defective viruses: integrated genomes, satellite virus and defective interfering particles. Complementation. The infectious clone. Gene expression in different types of viruses, temporary regulation strategies. Principles of reverse genetics. Tools for viral gene transfer and gene therapy. Presentation of antigen and peptides in recombinant viruses. Gene cloning and expression vectors of viral origin.
6. Origin and evolution of viruses
Origin of viruses and regressive theories for a cellular origin. Mechanisms of generation of diversity. Mutation frequencies and relative abundance of mutants. Fixation of mutations. Viral replicases and copying fidelity. Variability and evolution in RNA viruses and retroviruses. The viral quasispecies. Evolutionand evolutionary potential. Darwinian selection and Darwinian mutations. Founding effects and bottlenecks. Genetic and antigenic divergence, the influenza virus. Analysis of the viral phylogeny.
7. Emerging viruses and viral diseases
Emergence of new viral diseases. Host jump and viral reservoirs. Viral emergence and viral re-emergence. Environmental factors,social and technological factors. Importance of arthropod vectors. The human species as a terminal host. New emerging viruses and human viruses. Hemorrhagic fevers. The Ebola virus and human immunodeficiency virus. The new hepatic viruses. The continuing re-emergence of influenza virus and others.
8. Methods in Virology
Obtaining viral particles. The cell culture. Small and medium scale cell culture. Purification. Quantitative analysis of viral particles. Detection of viral components and applications in the diagnostic methodology. The virology laboratory: areas and distribution. The biological safety levels of containment: P1 to P4. Air treatment. Tributary treatment. Vaccine factories: industrial-scale up production of viral particles.
9. Viral taxonomy
Early classifications of viruses: Baltimore classification of animal viruses. The International Committee on Taxonomy of Viruses and the classification system. Properties used in viral taxonomy. Families of animal viruses and viruses not classified. The major human pathogens and their diseases.
10. Prions and viroids
Infectious proteins: the prion. Development of the prion concept. The amyloid. Synthesis and processing of PrPc. PrPsc formation and propagation of prions. Spongiform encephalopathies: inheritance and contagion. Phenotypic diversity of prions; strains. The "scrapie" and bovine spongiform encephalopaty. Interspecific barriers. The human spongiform encephalopathies: Kuru, Creutzfeldt-Jakob disease and hereditary diseases. Prions in yeast. Viroids: structure and consistency of domains. Possible pathogenetic mechanisms. The hepatitis delta.
11. Bacteriophages
Use of bacteriophages in molecular genetics and biotechnology. The "Phage Display". The generation of antibodies without immunization and the search for new ligands. Directed molecular evolution. Systems of selection of antiviral drugs: the case of protease inhibitors.
12. Viral pathogenesis
Characteristics of viral infections. Entry routes. Localized and systemic infections. Invasiveness. Viremia. Nerve transmission. Target tissues: tropism. Virulence. Role of organic response in the pathogenesis. Infection: transmission routes. Vectors and reservoirs. Persistent viral infections, mechanisms of persistence. The measles virus. The Epstein-Barr virus.Viral hepatitis. HIV infection; dynamic aspects of persistence. The movement of plant viruses.
13. Responses to viral infection
Non-specific antiviral mechanisms. Induction and activity of interferons. Induction and evolution of the immune response. Role of antibodies and T cells. Prophylaxis of viral infections: vaccination. Types of vaccines: attenuated and inactivated. Polio vaccines. Molecular basis of attenuation. New generation vaccines. Antigens and immunogens. Recombinant proteins and peptides. Pseudo-capsid vaccine. The vaccine against hepatitis B and papilloma viruses. Vaccination with DNA.
14. Artificial viruses
Viral gene therapy; important features and biological risks. Artificial viruses as alternatives to viral gene therapy. Types of artificial viruses and used biomolecules. Modular strategies. Selection of functional domains. Examples and applications of artificial viruses.
“*Unless the requirements enforced by the health authorities demand a prioritization or reduction of these contents.”
The course will comprise classroom lectures and active learning activities with scientific problems and cases by which students will acquire skills necessary to perform literature research, propose experimental approaches and design problem solving strategies. Oral presentations of active learning activities will encourage teamwork, coordination of activities and rational presentation of work plans and results. Active learning activities will be focused on methodological aspects and biomedical, biotechnology, pharmaceutical and nanotechnological applications of virus as well as derived viral structures. Personal tutorial guidance sessions will be available by email appointment and will be held in the office C3/331. In those sessions, students will have the opportunity to receive individual guidance according to their needs.
“*The proposed teaching methodology may experience some modifications depending on the restrictions to face-to-face activities enforced by health authorities.”
Title | Hours | ECTS | Learning Outcomes |
---|---|---|---|
Type: Directed | |||
Active learning activities | 15 | 0.6 | 10, 14, 12 |
Lectures | 30 | 1.2 | 11, 9, 8, 6, 7, 4, 5, 1, 2, 3, 13 |
Type: Supervised | |||
Personal tutorial guidance sessions | 2 | 0.08 | 11, 9, 8, 6, 7, 4, 5, 1, 2, 3, 10, 14, 12, 13 |
Type: Autonomous | |||
Group work: preparation of written reports | 2 | 0.08 | 10, 14, 12 |
Literature search | 28 | 1.12 | 10, 12 |
Personal study | 44 | 1.76 | 11, 9, 8, 6, 7, 4, 5, 1, 2, 3, 13 |
Preparation of oral and written presentation of reports | 1 | 0.04 | 10, 14, 12 |
Reading | 23 | 0.92 | 10, 14 |
EXAM TO GET A HIGHER GRADE: All those students who have passed both theory exams may retake the final exam to improve the grade of the subject. The student who wants to raise the mark (only theory) may re-examine the final exam (50 %) as long as he or she has expressed in writing (email) his/her willingness to take the exam tothe coordinator of thesubject at least ten days before the final exam. By taking the exam in order to get a higher grade, the student implicitly renounces the grade he or she had obtained in the final exam. The grade that will be taken into account will be that of the last exam the student has taken. There is no option to improve the other grades.
“*Student’s assessment may experience some modifications depending on the restrictions to face-to-face activities enforced by health authorities.”
Title | Weighting | Hours | ECTS | Learning Outcomes |
---|---|---|---|---|
Evaluation of group assignements: written report | 20 % | 0 | 0 | 10, 14, 12 |
Final exam: multiple choice | 50 % | 3 | 0.12 | 11, 9, 8, 6, 7, 4, 5, 1, 2, 3, 13 |
First midterm exam: multiple choice | 20 % | 2 | 0.08 | 9, 7, 1, 2, 3 |
Oral and/or written presentation of reports | 10 % | 0 | 0 | 10, 14, 12 |